Spleenex Liquid
NDC Package 44911-0294-1
Package Information
Spleenex (aralia quinquefolia, ginkgo biloba, pancreas suis, spleen (suis), stomach (suis), germanium sesquioxide, cobaltum metallicum, niccolum metallicum, zincum metallicum, alpha-ketoglutaricum acidum, citricum acidum, fumaricum acidum, malic acid, pyruvic acid, succinicum acidum, naphthoquinone, baryta carbonica, phosphoricum acidum, aconiticum acidum, cis, magnesium gluconicum dihydricum, nux vomica, phosphorus) liquids May temporarily relieve heaviness and fullness after eating little, stomach pain, and weak digestion.****Claims based on traditional homeopathic practice, not accepted medical evidence. This formulation utilizes a liquid delivery system. Marketed by Energique, Inc., this product is identified by NDC 44911-0294.
Identification & Billing
Clinical Specifications
- ACONITIC ACID, (Z)- 12 [hp_X]/mL
- AMERICAN GINSENG 3 [hp_X]/mL
- ANHYDROUS CITRIC ACID 8 [hp_X]/mL
- BARIUM CARBONATE 12 [hp_X]/mL
- COBALT 8 [hp_X]/mL
- FUMARIC ACID 8 [hp_X]/mL
- GERMANIUM SESQUIOXIDE 8 [hp_X]/mL
- GINKGO 6 [hp_X]/mL
- MAGNESIUM GLUCONATE 12 [hp_X]/mL
- MALIC ACID 8 [hp_X]/mL
- NAPHTHOQUINE 9 [hp_X]/mL
- NICKEL 8 [hp_X]/mL
- OXOGLURIC ACID 8 [hp_X]/mL
- PHOSPHORIC ACID 12 [hp_X]/mL
- PHOSPHORUS 12 [hp_X]/mL
- PYRUVIC ACID 8 [hp_X]/mL
- STRYCHNOS NUX-VOMICA SEED 12 [hp_X]/mL
- SUCCINIC ACID 8 [hp_X]/mL
- SUS SCROFA PANCREAS 6 [hp_X]/mL
- SUS SCROFA SPLEEN 6 [hp_X]/mL
- SUS SCROFA STOMACH 6 [hp_X]/mL
- ZINC 8 [hp_X]/mL
- Acidifying Activity - [MoA] (Mechanism of Action)
- Allergens - [CS]
- Anti-coagulant - [EPC] (Established Pharmacologic Class)
- Calcium Chelating Activity - [MoA] (Mechanism of Action)
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Decreased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
- Standardized Chemical Allergen - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 44911 - Energique, Inc.
- 44911-0294 - Spleenex
- 44911-0294-1 - 30 mL in 1 BOTTLE, DROPPER
- 44911-0294 - Spleenex
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 44911-0294-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Spleenex VH, a human over the counter drug labeled by Energique, Inc.. This liquid is formulated for oral use and contains aconitic acid, (z)-; american ginseng; anhydrous citric acid; barium carbonate; cobalt; fumaric acid; germanium sesquioxide; ginkgo; magnesium gluconate; malic acid; naphthoquine; nickel; oxogluric acid; phosphoric acid; phosphorus; pyruvic acid; strychnos nux-vomica seed; succinic acid; sus scrofa pancreas; sus scrofa spleen; sus scrofa stomach; zinc as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Energique, Inc. on November 11, 2015. The current certification is valid through December 31, 2026.
How is this Energique, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 44911029401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.